Literature DB >> 24561254

PTEN C-terminal deletion causes genomic instability and tumor development.

Zhuo Sun1, Chuanxin Huang2, Jinxue He2, Kristy L Lamb2, Xi Kang1, Tingting Gu2, Wen Hong Shen3, Yuxin Yin4.   

Abstract

Tumor suppressor PTEN controls genomic stability and inhibits tumorigenesis. The N-terminal phosphatase domain of PTEN antagonizes the PI3K/AKT pathway, but its C-terminal function is less defined. Here, we describe a knockin mouse model of a nonsense mutation that results in the deletion of the entire Pten C-terminal region, referred to as Pten(ΔC). Mice heterozygous for Pten(ΔC) develop multiple spontaneous tumors, including cancers and B cell lymphoma. Heterozygous deletion of the Pten C-terminal domain also causes genomic instability and common fragile site rearrangement. We found that Pten C-terminal disruption induces p53 and its downstream targets. Simultaneous depletion of p53 promotes metastasis without influencing the initiation of tumors, suggesting that p53 mainly suppresses tumor progression. Our data highlight the essential role of the PTEN C terminus in the maintenance of genomic stability and suppression of tumorigenesis.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24561254      PMCID: PMC4090077          DOI: 10.1016/j.celrep.2014.01.030

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  40 in total

1.  Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.

Authors:  D J Marsh; V Coulon; K L Lunetta; P Rocca-Serra; P L Dahia; Z Zheng; D Liaw; S Caron; B Duboué; A Y Lin; A L Richardson; J M Bonnetblanc; J M Bressieux; A Cabarrot-Moreau; A Chompret; L Demange; R A Eeles; A M Yahanda; E R Fearon; J P Fricker; R J Gorlin; S V Hodgson; S Huson; D Lacombe; C Eng
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

2.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.

Authors:  D Liaw; D J Marsh; J Li; P L Dahia; S I Wang; Z Zheng; S Bose; K M Call; H C Tsou; M Peacocke; C Eng; R Parsons
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

3.  High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.

Authors:  V Stambolic; M S Tsao; D Macpherson; A Suzuki; W B Chapman; T W Mak
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

4.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

Review 5.  FRA3B and other common fragile sites: the weakest links.

Authors:  K Huebner; C M Croce
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

6.  Lifetime cancer risks in individuals with germline PTEN mutations.

Authors:  Min-Han Tan; Jessica L Mester; Joanne Ngeow; Lisa A Rybicki; Mohammed S Orloff; Charis Eng
Journal:  Clin Cancer Res       Date:  2012-01-15       Impact factor: 12.531

7.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

Review 8.  The p53-deficient mouse: a model for basic and applied cancer studies.

Authors:  L A Donehower
Journal:  Semin Cancer Biol       Date:  1996-10       Impact factor: 15.707

Review 9.  Common fragile genes.

Authors:  A Matsuyama; C M Croce; K Huebner
Journal:  Eur J Histochem       Date:  2004       Impact factor: 3.188

10.  Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function.

Authors:  Amy N Anzelon; Hong Wu; Robert C Rickert
Journal:  Nat Immunol       Date:  2003-02-03       Impact factor: 25.606

View more
  45 in total

1.  PTEN regulates PLK1 and controls chromosomal stability during cell division.

Authors:  Zhong Zhang; Sheng-Qi Hou; Jinxue He; Tingting Gu; Yuxin Yin; Wen H Shen
Journal:  Cell Cycle       Date:  2016-07-11       Impact factor: 4.534

2.  PTEN Regulates Nonhomologous End Joining By Epigenetic Induction of NHEJ1/XLF.

Authors:  Parker L Sulkowski; Susan E Scanlon; Sebastian Oeck; Peter M Glazer
Journal:  Mol Cancer Res       Date:  2018-05-08       Impact factor: 5.852

3.  Pten regulates spindle pole movement through Dlg1-mediated recruitment of Eg5 to centrosomes.

Authors:  Janine H van Ree; Hyun-Ja Nam; Karthik B Jeganathan; Arun Kanakkanthara; Jan M van Deursen
Journal:  Nat Cell Biol       Date:  2016-05-30       Impact factor: 28.824

Review 4.  The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.

Authors:  Rui D Mendes; Kirsten Canté-Barrett; Rob Pieters; Jules P P Meijerink
Journal:  Haematologica       Date:  2016-09       Impact factor: 9.941

5.  The Msp Protein of Treponema denticola Interrupts Activity of Phosphoinositide Processing in Neutrophils.

Authors:  Megan M Jones; Stephen T Vanyo; Michelle B Visser
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

6.  PTEN as a Guardian of the Genome: Pathways and Targets.

Authors:  Xinyi Fan; Jeffrey Kraynak; Jonathan P S Knisely; Silvia C Formenti; Wen H Shen
Journal:  Cold Spring Harb Perspect Med       Date:  2020-09-01       Impact factor: 6.915

Review 7.  PTEN proteoforms in biology and disease.

Authors:  Prerna Malaney; Vladimir N Uversky; Vrushank Davé
Journal:  Cell Mol Life Sci       Date:  2017-03-13       Impact factor: 9.261

Review 8.  Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?

Authors:  A Lester; R Rapkins; S Nixdorf; M Khasraw; K McDonald
Journal:  Clin Transl Oncol       Date:  2016-09-21       Impact factor: 3.405

Review 9.  Genome maintenance in the context of 4D chromatin condensation.

Authors:  Sonia Yu; Fan Yang; Wen H Shen
Journal:  Cell Mol Life Sci       Date:  2016-04-20       Impact factor: 9.261

Review 10.  BRCAness revisited.

Authors:  Christopher J Lord; Alan Ashworth
Journal:  Nat Rev Cancer       Date:  2016-01-18       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.